Analysis
Can you buy Ozempic in Mexico or Canada and bring it into the US?
FDA personal-import rules, foreign approval versus U.S. approval, and why the three-month language is not blanket permission to import Ozempic.
Claims are checked against the sources cited in this article. Nothing here is individualized medical advice. How we research
On this page
Generally not as an ordinary personal import: as checked October 9, 2026, FDA says bringing drugs purchased abroad into the United States for personal use is illegal in most circumstances because the products often lack U.S. approval. Buying Ozempic in Mexico or Canada does not itself establish permission to import that package, and FDA’s limited discretionary policy is not a blanket three-month allowance. FDA personal-import guidance.
The country where a purchase is possible and the rules for entry into the U.S. answer different questions. This guide explains the official import framework, not whether a particular travel purchase will be admitted or how to bypass inspection. No Mexico or Canada retail price is quoted because a current, comparable product-specific offer was not established for this article.
Foreign approval is not automatically U.S. approval
FDA’s personal-import page distinguishes a drug approved in another country from a drug approved for use and sale in the United States. A foreign-market product can be unapproved in the U.S. even when its name or ingredient is familiar. Recognition of the Ozempic brand therefore should not be treated as confirmation that every foreign package is authorized for U.S. entry.
The relevant question concerns the actual finished product, not just a translation of its label or its active ingredient. Seller location, product labeling and approval status all matter. A pharmacist’s willingness to sell a package abroad is not an import decision by U.S. authorities.
FDA also says it cannot ensure the safety and effectiveness of medicines purchased online from foreign sources or during trips abroad. That is the agency’s stated limit, not an assessment of every individual Mexican or Canadian pharmacy. Country-level assumptions cannot authenticate a particular package or determine its admissibility.
The personal-import policy is discretionary
FDA defines personal importation as bringing in a product that is not intended for further sale or distribution into U.S. commerce. Personal use alone is not the same as a legal exemption. The guidance describes circumstances in which personnel may consider a more permissive decision regarding an otherwise noncompliant product.
For prescription products, the listed considerations include a serious condition for which effective treatment may not be available domestically, absence of U.S. commercialization or promotion, a risk assessment, a personal-use statement and treatment-related documentation. These are factors within a policy, not a customer checklist that guarantees admission after each box is checked.
FDA’s human-drug import information and drug FAQ supply additional background. A low foreign price or an expensive domestic prescription does not by itself establish that the discretionary policy applies to a purchase.
Why “a three-month supply is allowed” is misleading
The three-month language appears within FDA’s description of the circumstances it may consider. It is not a standalone promise that a U.S. resident may import any prescription medicine if the quantity stays under that amount.
| Common claim | What the FDA guidance actually distinguishes |
|---|---|
| It is for me, so importing it is allowed | Personal use defines the transaction; it does not establish an exemption |
| It is only three months, so it is legal | Quantity is one consideration within a broader discretionary framework |
| The drug is approved in Canada or Mexico | Foreign approval does not necessarily mean U.S. approval |
| My doctor wrote a prescription | A prescription does not independently settle the product’s import status |
| A friend brought the same brand back | Another person’s experience is not an official decision about this purchase |
These distinctions are especially important when a travel or shopping article presents the quantity language without the rest of the policy. Read the actual FDA page rather than relying on a shortened paraphrase that converts discretion into a right.
Visitors and returning U.S. residents are different contexts
FDA’s page has separate guidance for foreign nationals visiting the United States and for U.S. citizens. Its foreign-national discussion recognizes visitors bringing their own medication during a stay and describes a 90-day supply arrangement. That separate discussion should not be transferred into advice for a U.S. resident making a shopping trip.
Citizenship or visitor status, the actual product and other circumstances can affect which guidance is relevant. This article does not determine a reader’s immigration category or individual admissibility. The useful point is to find the correct official section before treating a general statement about travelers as permission for a different situation.
Mail or courier delivery also does not remove the import question. FDA’s personal-import framework addresses those channels as well as baggage. A foreign website offering shipment to a U.S. address is a seller’s service claim, not confirmation that authorities will admit the order.
Commercial import programs are not personal-shopping permission
FDA’s drug-import pages distinguish regulated import arrangements from an individual’s purchase abroad. News about a commercial program or an import authorization should be read for its actual participants, products and conditions. It should not be expanded into a right for any shopper to bring a similarly named product across the border.
Likewise, a U.S.-based storefront arranging foreign purchases does not eliminate the underlying regulatory question. FDA’s personal-import page expressly discusses businesses offering to buy foreign medicines for customers. Ask which official framework supports the specific transaction instead of assuming a domestic payment processor makes the supplied foreign product authorized.
A foreign price is not the complete comparison
An accurate price comparison would need the product form, strength, quantity, currency, date and retailer, plus any separate service or shipping charge. A foreign-market package might not match the domestic offer being compared. This guide does not substitute an unsourced travel anecdote for those details.
Even a verified retail price would not establish authenticity, a prescription’s appropriateness or lawful U.S. importation. Keep financial and regulatory questions separate. A cheap-looking quote is not a complete purchasing answer if the product identity and import conditions remain unresolved.
Our semaglutide guide and company directory link to provider information for U.S. care research. They do not establish that every provider is suitable for every person or that a foreign offer is interchangeable with a listed service.
Where to get a case-specific answer
Use FDA’s current guidance and official contact channels for import questions; discuss prescription and product concerns with the care team and dispensing pharmacist. Do not rely on a seller’s assurance, a border anecdote or an abbreviated three-month rule as an individual clearance.
The bottom line is that purchase abroad and admission into the United States are separate decisions. FDA’s generally restrictive rule and limited discretionary policy must be read together. Neither the Ozempic name, a prescription nor a small quantity alone makes a Mexico or Canada purchase automatically lawful to bring home.